Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery-Reference-Cited by-同舟云学术

Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery

Published:2005-05 Issue:5 Volume:20 Page:765-771
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:J Gastroenterol Hepatol

Author:

HUANG YI-HSIANG,CHEN CHIEN-HUNG,CHANG TING-TSUNG,CHEN SHINN-CHERNG,WANG SHEN-YUNG,LEE HSUAN-SHU,LIN PIN-WEN,HUANG GUAN-TARN,SHEU JIN-CHUAN,TSAI HONG-MING,LEE PUI-CHING,CHAU GAR-YANG,LUI WING-YIU,LEE SHOU-DONG,WU JAW-CHING

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1746.2005.03746.x/fullpdf

Reference21 articles.

1. Rising Incidence of Hepatocellular Carcinoma in the United States

2. Increase in primary liver cancer in the UK, 1979–94

3. Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection

4. Natural history of hepatocellular carcinoma and prognosis in relation to treatment study of 850 patients

5. Treatment options in Western hepatocellular carcinoma: a prospective study of 224 patients

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical significances of several fibrotic markers for prognosis in hepatocellular carcinoma patients who underwent hepatectomy;Translational Cancer Research;2024-05

2. Optimizing hepatocellular carcinoma disease staging systems by incorporating tumor micronecrosis: A multi-institutional retrospective study;Cancer Letters;2024-03

3. Development and External Validation of a Nomogram Including Body Composition Parameters for Predicting Early Recurrence of Hepatocellular Carcinoma After Hepatectomy;Academic Radiology;2023-12

4. The mesenchymal circulating tumor cells as biomarker for prognosis prediction and supervision in hepatocellular carcinoma;Journal of Cancer Research and Clinical Oncology;2023-01-12

5. Decreased expression of serum semaphorin 3B is associated with poor prognosis of patients with hepatocellular carcinoma;Experimental and Therapeutic Medicine;2021-01-21